Product
TQH2722 injection
2 clinical trials
2 indications
Indication
Atopic DermatitisIndication
Chronic RhinosinusitisClinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial Evaluating the Efficacy and Safety of TQH2722 Injection in Subjects With Moderate to Severe Atopic DermatitisStatus: Recruiting, Estimated PCD: 2024-03-01
Clinical trial
A Multicenter, Randomized, Continuing Trial to Evaluate the Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal PolypsStatus: Not yet recruiting, Estimated PCD: 2025-10-01